February 24, 2016
12:00 - 2:00 p.m. ET
Center for Strategic and International Studies (CSIS) building
1616 Rhode Island Ave. NW
Washington, DC 20036
David Litwack, Ph.D., Policy Advisor, FDA Office of In Vitro Diagnostics and Radiological Health, and Taha Kass-Hout, M.D., M.S., Chief Health Informatics Officer, FDA, and Director, Office of Health Informatics, FDA, will deliver remarks on the role of databases in next-generation sequencing (NGS) policy and the intended impact of precisionFDA.
The meeting follows several FDA workshops on NGS policy and the release of the related precisionFDA web platform, which the agency champions as a significant step forward for the Precision Medicine Initiative.